Is Enovix an Underrated Small Cap?
Enovix (NASDAQ:ENVX) is one of several small, innovative companies hoping…
Buy
70
IHI Quote, Financials, Valuation and Earnings
Last price:
$61.98
Seasonality move
:
4.15%
Day range:
$60.72 - $61.20
52-week range:
$52.90 - $65.18
Dividend yield:
0.45%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
858.5K
Avg. volume:
749.7K
1-year change:
8.72%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
$60.72 | -- | -- | -- | $0.03 | 0.45% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$152.78 | -- | -- | -- | $1.17 | 0.77% | -- |
|
IBB
iShares Biotechnology ETF
|
$116.63 | -- | -- | -- | $0.12 | 0.33% | -- |
|
IYH
iShares US Healthcare ETF
|
$55.35 | -- | -- | -- | $0.16 | 1.3% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$242.70 | -- | -- | -- | $0.94 | 1.64% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$76.39 | -- | -- | -- | $0.01 | 0.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | 1.198 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.052 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.260 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 0.913 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 0.976 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Medical Devices ETF vs. Competitors
-
Which has Higher Returns IHI or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About IHI or FBT?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe iShares US Medical Devices ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is IHI or FBT More Risky?
iShares US Medical Devices ETF has a beta of 0.951, which suggesting that the stock is 4.916% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.683, suggesting its less volatile than the S&P 500 by 31.689%.
-
Which is a Better Dividend Stock IHI or FBT?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.77% to investors and pays a quarterly dividend of $1.17 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or FBT?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns IHI or IBB?
iShares Biotechnology ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IHI or IBB?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than iShares Biotechnology ETF, analysts believe iShares US Medical Devices ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IHI or IBB More Risky?
iShares US Medical Devices ETF has a beta of 0.951, which suggesting that the stock is 4.916% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.818, suggesting its less volatile than the S&P 500 by 18.239%.
-
Which is a Better Dividend Stock IHI or IBB?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. iShares Biotechnology ETF offers a yield of 0.33% to investors and pays a quarterly dividend of $0.12 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or IBB?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IHI or IYH?
iShares US Healthcare ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About IHI or IYH?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than iShares US Healthcare ETF, analysts believe iShares US Medical Devices ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is IHI or IYH More Risky?
iShares US Medical Devices ETF has a beta of 0.951, which suggesting that the stock is 4.916% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.706, suggesting its less volatile than the S&P 500 by 29.382%.
-
Which is a Better Dividend Stock IHI or IYH?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. iShares US Healthcare ETF offers a yield of 1.3% to investors and pays a quarterly dividend of $0.16 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or IYH?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns IHI or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About IHI or VHT?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe iShares US Medical Devices ETF is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is IHI or VHT More Risky?
iShares US Medical Devices ETF has a beta of 0.951, which suggesting that the stock is 4.916% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.725, suggesting its less volatile than the S&P 500 by 27.532%.
-
Which is a Better Dividend Stock IHI or VHT?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. Vanguard Health Care Index Fund ETF offers a yield of 1.64% to investors and pays a quarterly dividend of $0.94 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or VHT?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
-
Which has Higher Returns IHI or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to iShares US Medical Devices ETF's net margin of --. iShares US Medical Devices ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHIiShares US Medical Devices ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About IHI or XBI?
iShares US Medical Devices ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Medical Devices ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe iShares US Medical Devices ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHIiShares US Medical Devices ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is IHI or XBI More Risky?
iShares US Medical Devices ETF has a beta of 0.951, which suggesting that the stock is 4.916% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock IHI or XBI?
iShares US Medical Devices ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.45%. SPDR S&P Biotech ETF offers a yield of 0.18% to investors and pays a quarterly dividend of $0.01 per share. iShares US Medical Devices ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHI or XBI?
iShares US Medical Devices ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. iShares US Medical Devices ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, iShares US Medical Devices ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Medical Devices ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHIiShares US Medical Devices ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Are We Heading Toward a Recession?
Fears of a recession in 2025 grew at the end…
3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 12
Regencell Bioscience Holdings [RGC] is up 27.78% over the past day.
Buy
97
NGVC alert for May 12
Natural Grocers by Vitamin Cottage [NGVC] is down 10.66% over the past day.
Sell
38
ONTO alert for May 12
Onto Innovation [ONTO] is up 4.62% over the past day.
